Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Program News

Member news

Research conducted in the laboratory of Ran Blekhman, Ph.D., has identified a single signature of colon cancer in the gut microbiome. Michael Burns, Ph.D., a postdoctoral fellow in the Blekhman lab and former Cancer Biology Training Grant fellow, was quoted in articles in the Minnesota Daily, Health Canal, EndoNurse, Medical Xpress, GenomeWeb, and VOA News. Timothy Starr, Ph.D., was also mentioned in the Minnesota Daily article. KSTP-TV also reported this.

Perry Hacket, Ph.D., Genetic Mechanisms of Cancer Program, was quoted in a Star Tribune story about the Sleeping Beauty transposon system he and his colleagues developed at the University of Minnesota, which is being used to develop new cancer treatments.

Reuben Harris, Ph.D., was selected by the Howard Hughes Medical Institute (HHMI) as one of 26 HHMI investigators, out of a pool of 894 applicants, based on scientific excellence. Read more.

The laboratory of Timothy Starr, Ph.D., recently reported the discovery of 76 lung cancer driver genes which could be therapeutic targets for treatment. The research was published in Molecular Cancer Research.

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on September 9, 2015